Articles

Lenalidomide plus cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab is safe and effective in untreated, elderly patients with diffuse large B-cell lymphoma: a phase I study by the Fondazione Italiana Linfomi

Hematology 2, Città della Salute e della Scienza, Hospital and University, Torino, Italy
Hematology Unit, Spedali Civili Hospital and University, Brescia, Italy
Hematology 2, Città della Salute e della Scienza, Hospital and University, Torino, Italy
Hematology and Transfusional Department, Cardinal Panico Hospital, Tricase-Lecce, Italy
Unit of Biostatistics, Epidemiology and Public Health, Department of Cardiac, Thoracic and Vascular Sciences, University of Padova, Genova, Italy
Hematology Unit, San Martino Hospital and University, Genova, Italy
Hematology 2, Città della Salute e della Scienza, Hospital and University, Torino, Italy
Hematology 1 and Molecular Biology, Città della Salute e della Scienza Hospital and University, Torino, Italy
Hematology Unit, SS. Antonio e Biagio e Cesare Arrigo Hospital, Alessandria, Italy
Hematology Unit, Santa Maria Hospital, Terni, Italy
Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
Hematology Unit, Spedali Civili Hospital and University, Brescia, Italy
Hematology and Transfusional Department, Cardinal Panico Hospital, Tricase-Lecce, Italy
Fondazione Italiana Linfomi Secretary, Alessandria, Italy
Hematology 2, Città della Salute e della Scienza, Hospital and University, Torino, Italy
Hematology 1 and Molecular Biology, Città della Salute e della Scienza Hospital and University, Torino, Italy
Unit of Cancer Epidemiology, University and CPO Piemonte, Torino, Italy
Hematology 1 and Molecular Biology, Città della Salute e della Scienza Hospital and University, Torino, Italy
Hematology Unit, Spedali Civili Hospital and University, Brescia, Italy
Hematology 2, Città della Salute e della Scienza, Hospital and University, Torino, Italy
Vol. 98 No. 11 (2013): November, 2013 https://doi.org/10.3324/haematol.2013.085134